Les nouvelles technologies dans la gestion du diabète de type 1 : Quelles sont-elles, quel est leur intérêt et quel rôle le pharmacien d’officine peut-il jouer ?

Ramilison, Christiana
(2026)

Files

Ramilison_Christiana_48072000_2025-2026.pdf
  • UCLouvain restricted access
  • Adobe PDF
  • 1.49 MB

Details

Supervisors
Henrard, Séverine
Faculty
Faculté de pharmacie et des sciences biomédicales
Degree label
Master [120] en sciences pharmaceutiques, à finalité spécialisée
Abstract
enType 1 diabetes (T1D) is a chronic condition that requires rigorous management and is associated with a significant physical and psychological burden, particularly among young adults. Technological advances offer new opportunities to improve disease management. Continuous glucose monitoring systems, inulin pumps, smart insulin pens, mobile applications and artificial intelligence-based tools are associated with improved glycemic control and quality of life. However, their use remains limited by economic, technical, and psychosocial constraints. These devices represent a major step toward more personalized T1D management, provided that equitable access and appropriate support from healthcare professionals are ensured. Consequently, the role of the pharmacist is evolving with the emergence of these new technologies.